Cancer clinical trials and research are the basis for virtually all advancement in cancer care. Through the careful study and evaluation of new treatments and therapies, clinical trials help uncover better ways to prevent, diagnose and treat cancer. Clinical trials can be a long, careful process. Often, they include many phases and last for many years.
Clinical trials may be conducted for any type of cancer, but the cancers most commonly studied are:
At Banner MD Anderson Cancer Center, eligible patients may be given the opportunity to participate in select research studies to help evaluate the safety and efficacy of new treatments and increase understanding of the ways to fight cancer.
By conducting independent cancer clinical trials as well as collaborating with physicians from MD Anderson Cancer Center and other research institutions recognized nationally and worldwide, our patients have access to some of the latest and most advanced trials.
Each clinical trial has its own unique benefits and risks.
Benefits of joining a clinical trial may include:
Some possible risks include:
The trial sponsor may pay for some of your medical care or tests. Before you join a trial, be sure to find out about any possible coverage opportunities.
We take the protection of our patients very seriously. First, all of our cancer clinical trials follow a well-planned protocol.
Second, we utilize a carefully informed consent process throughout every trial.
Third, like all clinical trials, those offered through Banner MD Anderson are monitored by an Institutional Review Board (IRB). This committee of doctors, nurses, chaplains, social workers, lawyers and patients helps ensure patients are protected and that all federal laws are followed. IRB files are audited by the U.S. Food and Drug Administration (FDA), which may visit the facility at any time to review programs and paperwork as well as interview those involved in clinical trials.